NCT02948790 (NeuriStim) is a NA clinical trial of Neuristim in Hearing Loss, Cochlear, sponsored by Oticon Medical.

Who is sponsoring NCT02948790?

NCT02948790 is sponsored by Oticon Medical.

What drugs are being tested in NCT02948790?

Interventions in NCT02948790: Neuristim, Cochlear implant.

What condition does NCT02948790 study?

NCT02948790 studies Hearing Loss, Cochlear, Neurinoma of the Acoustic Nerve.

Is NCT02948790 still recruiting?

NCT02948790 is currently completed. Last updated 20 October 2021.

Last reviewed 2021-10-20 · How we verify

NCT02948790: NeuriStim

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Auditory Nerve Monitoring Using Intra-cochlear Stimulation in Subjects With Acoustic Neuroma

Completed NA Last updated 20 October 2021

What this trial tests

NA trial testing Neuristim in Hearing Loss, Cochlear in 17 participants. Completed in 3 April 2019.

Timeline

7 April 2017

Primary endpoint
3 April 2019

3 April 2019

Quick facts

Lead sponsor	Oticon Medical
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	17
Start date	7 April 2017
Primary completion	3 April 2019
Estimated completion	3 April 2019
Sites	4 locations across France

Drugs / interventions tested

Neuristim
Cochlear implant

Conditions studied

Hearing Loss, Cochlear — all drugs for Hearing Loss, Cochlear →
Neurinoma of the Acoustic Nerve — all drugs for Neurinoma of the Acoustic Nerve →

Sponsor

Oticon Medical

Who can join

18 and older, any sex, with Hearing Loss, Cochlear or Neurinoma of the Acoustic Nerve. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess the auditory nerve functionality with an intraoperative approach following a surgical removal of acoustic neuroma in patients with severe to profound sensorineural hearing disabilities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hearing Loss, Cochlear

Currently open trials in the same condition.

NCT07287774 — Evaluating a Deep Neural Noise-Reduction Algorithm for Hearing Aids · NA · recruiting
NCT06664697 — Post-Market Clinical Investigation of the IotaSOFT Insertion System · recruiting

Other Oticon Medical trials

Trials by the same sponsor.

NCT07294976 — Evaluation of Actual Maximum Gain in Bone Anchored Devices · NA · recruiting
NCT06930781 — Evaluation of Clinical Outcomes of Ponto Procedures Performed in Settings Outside the Main Operating Room (i.e. Out-of-O · recruiting
NCT06976086 — Pediatric Expansion Study of the Sentio System · NA · recruiting
NCT06421766 — Retrospective Study of Outcomes With 3 mm Implant for Percutaneous BAHS Procedures · completed
NCT06638840 — Pediatric Performance and Satisfaction of Oticon Medical Ponto on Softband. · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02948790 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oticon Medical
Last refreshed: 20 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02948790.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing